Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2020

12.08.2020 | Review article

The effect of propolis on anthropometric indices and lipid profile: a systematic review and meta-analysis of randomized controlled trials

verfasst von: Ammar Salehi-Sahlabadi, Manik Chhabra, Jamal Rahmani, Aref Momeni, Giorgio Karam, Elyas Nattagh-Eshtivani, Mehran Nouri, Cain Clark, Pantea Salehi, Azita Hekmatdoost

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background & objective(s)

The current evidence base regarding the impact of propolis consumption on lipid profile in humans is equivocal. Thus, we sought to investigate the impact of propolis consumption on anthropometric indices and lipid profile in this meta-analysis.

Methods

Cochrane Library, Scopus, PubMed, and Web of Science electronic databases were searched up to December 2019. A random-effects model used to pool effect size. The leave-one-out method used to conduct sensitivity analysis.

Results

Five RCTs were included in this study. Our findings indicated a significant decrease in triglyceride (TG) (WMD: −3.91 mg/dl, 95% CI: −4.22, −3.60), and a significant increase in high-density lipoprotein (HDL) (WMD: 3.41 mg/dl, 95% CI: 0.05, 6.76), however, for body mass index, weight, cholesterol (CL), and low-density lipoprotein (LDL), no significant alterations were evident.

Conclusion

This study revealed that consumption of propolis is associated with a reduction in TG levels, in addition to an increase in HDL levels. Nevertheless, additional research is required to further delineate the relationship between propolis consumption and lipid profile.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:697390.CrossRef Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:697390.CrossRef
2.
Zurück zum Zitat Sforcin JM. Biological properties and therapeutic applications of propolis. Phytother Res. 2016;30(6):894–905.CrossRef Sforcin JM. Biological properties and therapeutic applications of propolis. Phytother Res. 2016;30(6):894–905.CrossRef
3.
Zurück zum Zitat Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res. 2001;15(7):561–71.CrossRef Banskota AH, Tezuka Y, Kadota S. Recent progress in pharmacological research of propolis. Phytother Res. 2001;15(7):561–71.CrossRef
4.
Zurück zum Zitat Silva BB, Rosalen PL, Cury JA, Ikegaki M, Souza VC, Esteves A, Alencar SM. Chemical composition and botanical origin of red propolis, a new type of brazilian propolis. Evid Based Complement Alternat Med. 2008;5(3):313–6.CrossRef Silva BB, Rosalen PL, Cury JA, Ikegaki M, Souza VC, Esteves A, Alencar SM. Chemical composition and botanical origin of red propolis, a new type of brazilian propolis. Evid Based Complement Alternat Med. 2008;5(3):313–6.CrossRef
5.
Zurück zum Zitat Machado CS, Mokochinski JB, de Lira TO, de Oliveira Fde C, Cardoso MV, Ferreira RG, et al. Comparative study of chemical composition and biological activity of yellow, green, brown, and red Brazilian propolis. Evid Based Complement Altern Med. 2016;2016:6057650. Machado CS, Mokochinski JB, de Lira TO, de Oliveira Fde C, Cardoso MV, Ferreira RG, et al. Comparative study of chemical composition and biological activity of yellow, green, brown, and red Brazilian propolis. Evid Based Complement Altern Med. 2016;2016:6057650.
6.
Zurück zum Zitat Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evid Based Complement Alternat Med. 2013;2013:964149.PubMedPubMedCentral Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evid Based Complement Alternat Med. 2013;2013:964149.PubMedPubMedCentral
7.
Zurück zum Zitat Szliszka E, Kucharska AZ, Sokol-Letowska A, Mertas A, Czuba ZP, Krol W. Chemical composition and anti-inflammatory effect of ethanolic extract of Brazilian green propolis on activated J774A.1 macrophages. Evid Based Complement Alternat Med. 2013;2013:976415.PubMedPubMedCentral Szliszka E, Kucharska AZ, Sokol-Letowska A, Mertas A, Czuba ZP, Krol W. Chemical composition and anti-inflammatory effect of ethanolic extract of Brazilian green propolis on activated J774A.1 macrophages. Evid Based Complement Alternat Med. 2013;2013:976415.PubMedPubMedCentral
8.
Zurück zum Zitat de Groot AC. Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis. 2013;24(6):263–82.CrossRef de Groot AC. Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis. 2013;24(6):263–82.CrossRef
9.
Zurück zum Zitat Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KM, Silva AM, et al. Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem. 2013;21(24):7570–7.CrossRef Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KM, Silva AM, et al. Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem. 2013;21(24):7570–7.CrossRef
10.
Zurück zum Zitat Kurek-Gorecka A, Rzepecka-Stojko A, Gorecki M, Stojko J, Sosada M, Swierczek-Zieba G. Structure and antioxidant activity of polyphenols derived from propolis. Molecules. 2013;19(1):78–101.CrossRef Kurek-Gorecka A, Rzepecka-Stojko A, Gorecki M, Stojko J, Sosada M, Swierczek-Zieba G. Structure and antioxidant activity of polyphenols derived from propolis. Molecules. 2013;19(1):78–101.CrossRef
11.
Zurück zum Zitat Shinohara R, Ohta Y, Hayashi T, Ikeno T. Evaluation of antilipid peroxidative action of propolis ethanol extract. Phytother Res. 2002;16(4):340–7.CrossRef Shinohara R, Ohta Y, Hayashi T, Ikeno T. Evaluation of antilipid peroxidative action of propolis ethanol extract. Phytother Res. 2002;16(4):340–7.CrossRef
12.
Zurück zum Zitat Jin UH, Chung TW, Kang SK, Suh SJ, Kim JK, Chung KH, Gu YH, Suzuki I, Kim CH. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta. 2005;362(1–2):57–64.CrossRef Jin UH, Chung TW, Kang SK, Suh SJ, Kim JK, Chung KH, Gu YH, Suzuki I, Kim CH. Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta. 2005;362(1–2):57–64.CrossRef
13.
Zurück zum Zitat Ichi I, Hori H, Takashima Y, Adachi N, Kataoka R, Okihara K, Hashimoto K, Kojo S. The beneficial effect of propolis on fat accumulation and lipid metabolism in rats fed a high-fat diet. J Food Sci. 2009;74(5):H127–31.CrossRef Ichi I, Hori H, Takashima Y, Adachi N, Kataoka R, Okihara K, Hashimoto K, Kojo S. The beneficial effect of propolis on fat accumulation and lipid metabolism in rats fed a high-fat diet. J Food Sci. 2009;74(5):H127–31.CrossRef
14.
Zurück zum Zitat Nader MA, el-Agamy DS, Suddek GM. Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch Pharm Res. 2010;33(4):637–43.CrossRef Nader MA, el-Agamy DS, Suddek GM. Protective effects of propolis and thymoquinone on development of atherosclerosis in cholesterol-fed rabbits. Arch Pharm Res. 2010;33(4):637–43.CrossRef
15.
Zurück zum Zitat Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510. Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510.
16.
Zurück zum Zitat Braakhuis A. Evidence on the health benefits of supplemental propolis. Nutrients. 2019;11(11):2705. Braakhuis A. Evidence on the health benefits of supplemental propolis. Nutrients. 2019;11(11):2705.
17.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.CrossRef
18.
Zurück zum Zitat Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRef Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRef
19.
Zurück zum Zitat Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. 2019;9(1):7289.CrossRef Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of Iranian propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. 2019;9(1):7289.CrossRef
20.
Zurück zum Zitat Samadi N, Mozaffari-Khosravi H, Rahmanian M, Askarishahi M. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial. J Integr Med. 2017;15(2):124–34.CrossRef Samadi N, Mozaffari-Khosravi H, Rahmanian M, Askarishahi M. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial. J Integr Med. 2017;15(2):124–34.CrossRef
21.
Zurück zum Zitat Mujica V, Orrego R, Perez J, Romero P, Ovalle P, Zuniga-Hernandez J, et al. The role of propolis in oxidative stress and lipid metabolism: a randomized controlled trial. Evid Based Complement Alternat Med. 2017;2017:4272940.CrossRef Mujica V, Orrego R, Perez J, Romero P, Ovalle P, Zuniga-Hernandez J, et al. The role of propolis in oxidative stress and lipid metabolism: a randomized controlled trial. Evid Based Complement Alternat Med. 2017;2017:4272940.CrossRef
22.
Zurück zum Zitat Afsharpour F, Hashemipour S, Khadem-Haghighian H, Koushan Y. Effects of Iranian propolis on glycemic status, inflammatory factors, and liver enzyme levels in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. J Nutr Sci Diet. 2017;3(2):9–14. Afsharpour F, Hashemipour S, Khadem-Haghighian H, Koushan Y. Effects of Iranian propolis on glycemic status, inflammatory factors, and liver enzyme levels in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. J Nutr Sci Diet. 2017;3(2):9–14.
23.
Zurück zum Zitat Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, et al. Effect of Brazilian green propolis in patients with type 2 diabetes: a double-blind randomized placebo-controlled study. Biomed Rep. 2015;3(3):355–60.CrossRef Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, et al. Effect of Brazilian green propolis in patients with type 2 diabetes: a double-blind randomized placebo-controlled study. Biomed Rep. 2015;3(3):355–60.CrossRef
24.
Zurück zum Zitat Machado JL, Assunçao AKM, da Silva MCP, Reis ASD, Costa GC, Arruda DDS, et al. Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity. Evid-Based Complement Altern Med. 2012;2012:157652.CrossRef Machado JL, Assunçao AKM, da Silva MCP, Reis ASD, Costa GC, Arruda DDS, et al. Brazilian green propolis: anti-inflammatory property by an immunomodulatory activity. Evid-Based Complement Altern Med. 2012;2012:157652.CrossRef
25.
Zurück zum Zitat Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KMP, Silva AM, Borges RM, Silva AJR, Valença SS, Porto LC. Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem. 2013;21(24):7570–7.CrossRef Lopes AA, Ferreira TS, Nesi RT, Lanzetti M, Pires KMP, Silva AM, Borges RM, Silva AJR, Valença SS, Porto LC. Antioxidant action of propolis on mouse lungs exposed to short-term cigarette smoke. Bioorg Med Chem. 2013;21(24):7570–7.CrossRef
26.
Zurück zum Zitat Bueno-Silva B, Alencar SM, Koo H, Ikegaki M, Silva GV, Napimoga MH, et al. Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis. J Agric Food Chem. 2013;61(19):4546–50.CrossRef Bueno-Silva B, Alencar SM, Koo H, Ikegaki M, Silva GV, Napimoga MH, et al. Anti-inflammatory and antimicrobial evaluation of neovestitol and vestitol isolated from Brazilian red propolis. J Agric Food Chem. 2013;61(19):4546–50.CrossRef
27.
Zurück zum Zitat Fan Y, Ma L, Zhang W, Wang J, Chen Y, Gao Y, Feng W, Zhong L, Song X. The design of propolis flavone microemulsion and its effect on enhancing the immunity and antioxidant activity in mice. Int J Biol Macromol. 2014;65:200–7.CrossRef Fan Y, Ma L, Zhang W, Wang J, Chen Y, Gao Y, Feng W, Zhong L, Song X. The design of propolis flavone microemulsion and its effect on enhancing the immunity and antioxidant activity in mice. Int J Biol Macromol. 2014;65:200–7.CrossRef
28.
Zurück zum Zitat Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:1–13.CrossRef Toreti VC, Sato HH, Pastore GM, Park YK. Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid Based Complement Alternat Med. 2013;2013:1–13.CrossRef
29.
Zurück zum Zitat Yonar ME, Yonar SM, Silici S. Protective effect of propolis against oxidative stress and immunosuppression induced by oxytetracycline in rainbow trout (Oncorhynchus mykiss, W.). Fish Shellfish Immunol. 2011;31(2):318–25.CrossRef Yonar ME, Yonar SM, Silici S. Protective effect of propolis against oxidative stress and immunosuppression induced by oxytetracycline in rainbow trout (Oncorhynchus mykiss, W.). Fish Shellfish Immunol. 2011;31(2):318–25.CrossRef
30.
Zurück zum Zitat Silva V, Genta G, MaN M, Masner M, Thomson L, Romero N, et al. Antioxidant activity of Uruguayan propolis. In vitro and cellular assays. J Agric Food Chem. 2011;59(12):6430–7.CrossRef Silva V, Genta G, MaN M, Masner M, Thomson L, Romero N, et al. Antioxidant activity of Uruguayan propolis. In vitro and cellular assays. J Agric Food Chem. 2011;59(12):6430–7.CrossRef
31.
Zurück zum Zitat Araujo MA, Libério SA, Guerra RN, Ribeiro MNS, Nascimento FR. Mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: a brief review. Rev Bras. 2012;22(1):208–19. Araujo MA, Libério SA, Guerra RN, Ribeiro MNS, Nascimento FR. Mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: a brief review. Rev Bras. 2012;22(1):208–19.
32.
Zurück zum Zitat Li Y, Chen M, Xuan H, Hu F. Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med. 2012;31(2):318–25. Li Y, Chen M, Xuan H, Hu F. Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evid Based Complement Alternat Med. 2012;31(2):318–25.
33.
Zurück zum Zitat Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis. 2007;191(2):265–71.CrossRef Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis. 2007;191(2):265–71.CrossRef
34.
Zurück zum Zitat Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, Ferri L, Desideri G. Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr. 2008;138(8):1554S–60S.CrossRef Grassi D, Aggio A, Onori L, Croce G, Tiberti S, Ferri C, Ferri L, Desideri G. Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr. 2008;138(8):1554S–60S.CrossRef
Metadaten
Titel
The effect of propolis on anthropometric indices and lipid profile: a systematic review and meta-analysis of randomized controlled trials
verfasst von
Ammar Salehi-Sahlabadi
Manik Chhabra
Jamal Rahmani
Aref Momeni
Giorgio Karam
Elyas Nattagh-Eshtivani
Mehran Nouri
Cain Clark
Pantea Salehi
Azita Hekmatdoost
Publikationsdatum
12.08.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2020
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-020-00604-2

Weitere Artikel der Ausgabe 2/2020

Journal of Diabetes & Metabolic Disorders 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.